Journal of Neuro-Oncology

, Volume 102, Issue 1, pp 121–127 | Cite as

Prospective neuraxis MRI surveillance reveals a high risk of leptomeningeal dissemination in diffuse intrinsic pontine glioma

  • Rajni Sethi
  • Jeffrey Allen
  • Bernadine Donahue
  • Matthias Karajannis
  • Sharon Gardner
  • Jeffrey Wisoff
  • Saroj Kunnakkat
  • Jeena Mathew
  • David Zagzag
  • Kia Newman
  • Ashwatha Narayana
Clinical Study - Patient Studies

Abstract

Prognosis of diffuse intrinsic pontine gliomas (DIPGs) remains poor. Failure has been predominantly local, with leptomeningeal dissemination (LD) occurring in 4–33% of patients in pre-MRI era series. Routine craniospinal imaging after initial treatment may reveal other relapse patterns relapse. Sixteen consecutive pediatric patients with DIPG treated between 2006 and 2009 were retrospectively reviewed. Treatment regimens, recurrence patterns, survival, and pathologic diagnosis were recorded. Fourteen patients received involved-field radiotherapy to 54 Gy, and two patients received craniospinal irradiation for LD at presentation. Neuraxis MRI was performed at diagnosis and at 4 month intervals following radiotherapy. Fifteen patients have had progression of disease (median progression-free survival 5.0 ± 1.2 months), and 13 patients have died (median survival 9.0 ± 1.4 months). Local failure occurred in 12 patients (75%). LD occurred in nine patients (56%). LD was present at diagnosis in three patients, after initial staging and treatment in six patients, and during autopsy in two patients. Median overall survival was 12.0 ± 3.3 months without LD and 8.0 ± 2.1 months with LD (P = 0.059, log rank test). Median progression-free survival was 9.5 ± 3.9 months without LD and 3.0 ± 2.1 months with LD (P = 0.012, log rank test). The high incidence of LD probably reflects liberal use of spine MRI surveillance. All patients should undergo routine craniospinal imaging at diagnosis and follow-up. Central nervous system prophylaxis should be considered in future clinical trials.

Keywords

Diffuse intrinsic pontine glioma Leptomeningeal dissemination Radiotherapy 

Notes

Conflicts of interest statement

None

References

  1. 1.
    Edwards MB, Prados M (1987) Current management of brainstem gliomas. Neurosci 13:309–315Google Scholar
  2. 2.
    Albright AL, Guthkelch AN, Packer RJ, Price RA, Rourke LB (1986) Prognostic factors in pediatric brain stem gliomas. J Neurosurg 65:751–755CrossRefPubMedGoogle Scholar
  3. 3.
    Hargrave D, Bartels U, Bouffet E (2006) Diffuse brainstem glioma in children: a critical review of clinical trials. Lancet Oncol 7:241–248CrossRefPubMedGoogle Scholar
  4. 4.
    Donaldson SS (2006) Advances toward and understanding of brainstem gliomas. J Clin Oncol 24:1266–1272CrossRefPubMedGoogle Scholar
  5. 5.
    Pierre-Kahn A, Hirsch JF, Vinchon M, Payan C, Sainte-Rose C, Renier D, Lelouch-Tubiana A, Fermanian J (1993) Surgical management of brain-stem tumors in children: results and statistical analysis of 75 cases. J Neurosurg 79:845–852CrossRefPubMedGoogle Scholar
  6. 6.
    Epstein F, McCleary E (1988) Intrinsic brain-stem tumors of childhood: surgical indications. J Neurosurg 64:309–317Google Scholar
  7. 7.
    Freeman CR, Krischer J, Sanford RA, Burger PC, Cohen M, Norris D (1988) Hyperfractionated radiotherapy in brain stem tumors: results of a pediatric oncology group study. Int J Radiat Oncol Biol Phys 15:311–318CrossRefPubMedGoogle Scholar
  8. 8.
    Freeman CR, Krischer JP, Sanford RA, Cohen ME, Burger PC, del Carpio R, Halperin EC, Munoz L, Friedman HS, Kun LE (1993) Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a pediatric oncology group study. Int J Radiat Oncol Biol Phys 27:197–206PubMedGoogle Scholar
  9. 9.
    Freeman CR, Kepner J, Kun LE, Sanford RA, Kadota R, Mandell L, Friedman H (2000) A detrimental effect of a combined chemotherapy-radiotherapy approach in children with diffuse intrinsic brain stem gliomas. Int J Radiat Oncol Biol Phys 47:561–564CrossRefPubMedGoogle Scholar
  10. 10.
    Walter AW, Gajjar A, Ochs JS, Langston JW, Sanford RA, Kun LE, Heideman R (1998) Carboplatin and etoposide with hyperfractionated radiotherapy in children with newly diagnosed diffuse pontine gliomas: a phase I/II study. Med Pediatr Oncol 30:28–33CrossRefPubMedGoogle Scholar
  11. 11.
    Mandell LR, Kadota R, Freeman C, Douglass EC, Fontanesi J, Cohen ME, Kovnar E, Burger P, Sanford RA, Kepner J, Friedman H, Kun LE (1999) There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a pediatric oncology group phase III trial comparing conventional versus hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys 43:959–964CrossRefPubMedGoogle Scholar
  12. 12.
    Packer RJ, Littman PA, Sposto RM, D’Angio G, Priest JR, Heideman RL, Bruce DA, Nelson DF (1987) Results of a pilot study of hyperfractionated radiation therapy for children with brain stem gliomas. Int J Radiat Oncol Biol Phys 13:1647–1651CrossRefPubMedGoogle Scholar
  13. 13.
    Packer RJ, Allen JC, Goldwein JL et al (1990) Hyperfractionated radiotherapy for children with brainstem gliomas: a pilot study using 7,200 cGy. Ann Neurol 27:167–173CrossRefPubMedGoogle Scholar
  14. 14.
    Packer RJ, Boyett JM, Zimmerman RA, Rorke LB, Kaplan AM, Albright AL, Selch MT, Finlay JL, Hammond GD, Wara WM (1993) Hyperfractionated radiotherapy (72 Gy) for children with brain stem gliomas: a children’s cancer group phase I/II trial. Cancer 72:1414–1421CrossRefPubMedGoogle Scholar
  15. 15.
    Packer RJ, Boyett JM, Zimmerman RA, Albright AL, Kaplan AM, Rorke LB, Selch MT, Cherlow JM, Finlay JL, Wara WM (1994) Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. Cancer 74:1827–1834CrossRefPubMedGoogle Scholar
  16. 16.
    Edwards MS, Wara WM, Urtasun RC, Prados M, Levin VA, Fulton D, Wilson CB, Hannigan J, Silver P (1989) Hyperfractionated radiotherapy for brain-stem glioma: a phase I\II trial. J Neurosurg 70:691–700CrossRefPubMedGoogle Scholar
  17. 17.
    Prados MD, Wara WM, Edwards MS, Larson DA, Lamborn K, Levin VA (1995) The treatment of brain stem and thalamic gliomas with 78 Gy of hyperfractionated radiation therapy. Int J Radiat Oncol Biol Phys 32:85–91CrossRefPubMedGoogle Scholar
  18. 18.
    Packer RJ, Allen J, Nielsen S, Petito C, Deck M, Jereb B (1983) Brainstem glioma: clinical manifestations of meningeal gliomatosis. Ann Neurol 72:1414–1421Google Scholar
  19. 19.
    Littman P, Jarrett P, Bilaniuk LT, Rorke LB, Zimmerman RA, Bruce DA, Carabell SC, Schut L (1980) Pediatric brainstem gliomas. Cancer 45:2787–2792CrossRefPubMedGoogle Scholar
  20. 20.
    Mantravadi RV, Phatak R, Bellur S, Liebner EJ, Haas R (1982) Brain stem gliomas: an autopsy study of 25 cases. Cancer 49:1294–1296CrossRefPubMedGoogle Scholar
  21. 21.
    Freeman CR, Suissa S (1986) Brain stem tumors in children: results of a survey of 62 patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 12:1923–1928CrossRefGoogle Scholar
  22. 22.
    Kretschmar CS, Tarbell NJ, Barnes PD, Krischer JP, Burger PC, Kun L (1993) Pre-irradiation chemotherapy and hyperfractionated radiation therapy 66 Gy for children with brain stem tumors—a phase II study of the pediatric oncology group, protocol 8833. Cancer 72:1404–1413CrossRefPubMedGoogle Scholar
  23. 23.
    Freeman CR, Krischer J, Sanford RA, Cohen ME, Burger PC, Kun L, Halperin EC, Crocker I, Wharam M (1991) Hyperfractionated radiotherapy for brain stem tumors: results at the 7020 cGy dose level of pediatric oncology group study #8495. Cancer 68:474–481CrossRefPubMedGoogle Scholar
  24. 24.
    Packer RJ, Krailo M, Mehta M, Warren K, Allen J, Jakacki R, Villablanca JG, Chiba A, Reaman G (2005) Phase 1 study of concurrent RMP-7 and carboplatin with radiotherapy for children with newly diagnosed brainstem gliomas. Cancer 104:1281–1287CrossRefPubMedGoogle Scholar
  25. 25.
    Packer RJ, Prados M, Phillips P, Nicholson HS, Boyett JM, Goldwein J, Rorke LB, Needle MN, Sutton L, Zimmerman RA, Fitz CR, Vezina LG, Etcubanas E, Wallenberg JC, Reaman G, Wara W (1996) Treatment of children with newly diagnosed brain stem gliomas with intravenous recombinant beta-interferon and hyperfractionated radiation therapy: a childrens cancer group phase I/II study. Cancer 77:2150–2156CrossRefPubMedGoogle Scholar
  26. 26.
    Allen J, Siffert J, Donahue B, Nirenberg A, Jakacki R, Robertson P, DaRosso R, Thoron L, Rosovsky M, Pinto R (1999) A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas. Cancer 86:1064–1069CrossRefPubMedGoogle Scholar
  27. 27.
    Jakacki RI, Siffert J, Jamison C, Velasquez L, Allen JC (1999) Dose-intensive, time-compressed procarbazine, CCNU, vincristine (PCV) with peripheral blood stem cell support and concurrent radiation in patients with newly diagnosed high-grade gliomas. J Neurooncol 44:77–83CrossRefPubMedGoogle Scholar
  28. 28.
    Jennings MT, Sposto R, Boyett JM, Vezina LG, Holmes E, Berger MS, Bruggers CS, Bruner JM, Chan KW, Dusenbery KE, Ettinger LJ, Fitz CR, Lafond D, Mandelbaum DE, Massey V, McGuire W, McNeely L, Moulton T, Pollack IF, Shen V (2002) Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the children’s cancer group. J Clin Oncol 20:3431–3437CrossRefPubMedGoogle Scholar
  29. 29.
    Broniscer A, Iacono L, Chintagumpala M, Fouladi M, Wallace D, Bowers DC, Stewart C, Krasin MJ, Gajjar A (2005) Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98). Cancer 103:133–1139CrossRefPubMedGoogle Scholar
  30. 30.
    Donahue B, Allen J, Siffert J, Rosovsky M, Pinto R (1998) Patterns of recurrence in brain stem gliomas: evidence for craniospinal dissemination. Int J Radiat Oncol Biol Phys 40:677–680CrossRefPubMedGoogle Scholar
  31. 31.
    Wagner S, Benesch M, Berthold F, Gnekow AK, Rutkowski S, Sträter R, Warmuth-Metz M, Kortmann RD, Pietsch T, Wolff JE (2006) Secondary dissemination in children with high-grade malignant gliomas and diffuse intrinsic pontine gliomas. Br J Cancer 95:991–997CrossRefPubMedGoogle Scholar
  32. 32.
    Benesch M, Wagner S, Berthold F, Wolff JE (2005) Primary dissemination of high-grade gliomas in children: experiences from four studies of the pediatric oncology and hematology society of the german language group (GPOH). J Neurooncol 72:179–183CrossRefPubMedGoogle Scholar
  33. 33.
    Gururangan S, McLaughlin CA, Brashears J, Watral MA, Provenzale J, Coleman RE, Halperin EC, Quinn J, Reardon D, Vredenburgh J, Friedman A, Friedman HS (2006) Incidence and patterns of neuraxis metastases in children with diffuse pontine glioma. J Neurooncol 77:207–212CrossRefPubMedGoogle Scholar
  34. 34.
    Hayward RM, Patronas N, Baker EH, Vézina G, Albert PS, Warren KE (2008) Inter-observer variability in the measurement of diffuse intrinsic pontine gliomas. J Neurooncol 90:57–61CrossRefPubMedGoogle Scholar
  35. 35.
    Onda K, Tanaka R, Takahashi H, Takeda N, Ikuta F (1989) Cerebral glioblastoma with cerebrospinal fluid dissemination: a clinicopathological study of 14 cases examined by complete autopsy. Neurosurgery 25:533–540CrossRefPubMedGoogle Scholar
  36. 36.
    Stark AM, Nabavi A, Mehdorn HM, Blomer U (2005) Glioblastoma multiforme—report of 267 cases treated at a single institution. Surg Neurol 63:162–169CrossRefPubMedGoogle Scholar
  37. 37.
    Becher OJ, Hambardzumyan D, Walker TR, Helmy K, Nazarian J, Albrecht S, Hiner RL, Gall S, Huse JT, Jabado N, MacDonald TJ, Holland EC (2010) Preclinical evaluation of radiation and perifosine in a genetically and histologically accurate model of brainstem glioma. Cancer Res 70:2548–2557CrossRefPubMedGoogle Scholar
  38. 38.
    Zarghooni M, Bartels U, Lee E, Buczkowicz P, Morrison A, Huang A, Bouffet E, Hawkins C (2010) Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets. J Clin Oncol 28:1337–1344CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2010

Authors and Affiliations

  • Rajni Sethi
    • 1
  • Jeffrey Allen
    • 2
    • 3
  • Bernadine Donahue
    • 1
    • 6
  • Matthias Karajannis
    • 2
  • Sharon Gardner
    • 2
  • Jeffrey Wisoff
    • 4
  • Saroj Kunnakkat
    • 1
  • Jeena Mathew
    • 2
  • David Zagzag
    • 5
  • Kia Newman
    • 5
  • Ashwatha Narayana
    • 1
    • 4
  1. 1.Department of Radiation OncologyNew York University Langone Medical CenterNew YorkUSA
  2. 2.Department of PediatricsNew York University Langone Medical CenterNew YorkUSA
  3. 3.Department of NeurologyNew York University Langone Medical CenterNew YorkUSA
  4. 4.Department of NeurosurgeryNew York University Langone Medical CenterNew YorkUSA
  5. 5.Department of PathologyNew York University Langone Medical CenterNew YorkUSA
  6. 6.Department of Radiation OncologyMaimonides Medical CenterBrooklynUSA

Personalised recommendations